JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$880M
| $214K | ﹤0.01% |
9,610
-37,500
| -80% | -$803K |
2018 Q3
7 quarters
|
|
|
FPRX
4052
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $214K | ﹤0.01% |
35,000
+2,500
| +8% | +$10.3K |
2020 Q1
1 quarter
|
|
|
FPRX
4053
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $214K | ﹤0.01% |
35,000
+2,500
| +8% | +$10.3K |
2020 Q1
1 quarter
|
|
4054
Legend Biotech
LEGN
$3.65B
| $213K | ﹤0.01% |
+5,000
| New | +$195K |
2020 Q2
0 quarters
|
|
4055
Uranium Energy
UEC
$4.63B
| $213K | ﹤0.01% |
242,692
-111,409
| -31% | -$108K |
2016 Q1
17 quarters
|
|
4056
ROBO Global Robotics & Automation Index ETF
ROBO
$2.1B
| $212K | ﹤0.01% |
4,876
-63
| -1% | -$2.5K |
2017 Q2
12 quarters
|
|
|
MNRL
4057
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $212K | ﹤0.01% |
17,119
-1,400
| -8% | -$17K |
2019 Q2
4 quarters
|
|
4058
Global X Copper Miners ETF NEW
COPX
$7.38B
| $211K | ﹤0.01% |
11,955
+10,338
| +639% | +$154K |
2019 Q3
3 quarters
|
|
4059
DHI Group
DHX
$209M
| $211K | ﹤0.01% |
100,795
+82,783
| +460% | +$213K |
2019 Q2
4 quarters
|
|
4060
Merchants Bancorp
MBIN
$2.28B
| $211K | ﹤0.01% |
17,180
-27,672
| -62% | -$292K |
2017 Q4
10 quarters
|
|
4061
HF Foods Group
HFFG
$89M
| $210K | ﹤0.01% |
23,203
-3,683
| -14% | -$26.8K |
2018 Q4
6 quarters
|
|
4062
Oric Pharmaceuticals
ORIC
$1.29B
| $210K | ﹤0.01% |
+6,217
| New | +$198K |
2020 Q2
0 quarters
|
|
4063
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16B
| $210K | ﹤0.01% |
7,904
-11,469
| -59% | -$282K |
2018 Q4
6 quarters
|
|
4064
Transmedics
TMDX
$2.88B
| $210K | ﹤0.01% |
11,762
-11,289
| -49% | -$177K |
2019 Q2
4 quarters
|
|
4065
iShares MSCI China A ETF
CNYA
$197M
| $209K | ﹤0.01% |
6,612
+4,380
| +196% | +$128K |
2020 Q1
1 quarter
|
|
4066
MasterCraft Boat Holdings
MCFT
$480M
| $209K | ﹤0.01% |
10,945
-46,331
| -81% | -$583K |
2017 Q4
10 quarters
|
|
4067
Sprott Physical Gold and Silver Trust
CEF
$7.28B
| $208K | ﹤0.01% |
12,285
-1,815
| -13% | -$28.9K |
2018 Q1
9 quarters
|
|
4068
Turning Point Brands
TPB
$1.16B
| $208K | ﹤0.01% |
8,354
+5,686
| +213% | +$131K |
2017 Q4
10 quarters
|
|
4069
CNB Financial Corp
CCNE
$1.01B
| $207K | ﹤0.01% |
11,555
-24,029
| -68% | -$406K |
2017 Q4
10 quarters
|
|
|
GLOG
4070
DELISTED
GASLOG LTD
GLOG
| $207K | ﹤0.01% |
73,605
-427,439
| -85% | -$1.56M |
2015 Q1
21 quarters
|
|
4071
Anavex Life Sciences
AVXL
$153M
| $206K | ﹤0.01% |
41,884
+28,139
| +205% | +$106K |
2019 Q2
4 quarters
|
|
|
PDS
4072
Precision Drilling
PDS
$1.11B
| $206K | ﹤0.01% |
13,601
+13,596
| +271,920% | +$152K |
2017 Q3
11 quarters
|
|
4073
CALL
Tilray
TLRY
$550M
| $206K | ﹤0.01% |
+2,900
| New | +$234K |
2020 Q2
0 quarters
|
|
4074
SmartFinancial
SMBK
$865M
| $205K | ﹤0.01% |
12,675
-19,384
| -60% | -$283K |
2017 Q4
10 quarters
|
|
|
RUTH
4075
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $205K | ﹤0.01% |
25,151
-118,085
| -82% | -$1.03M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.